home All News open_in_new Full Article

Los fármacos antiobesidad Ozempic, Wegoby, Mounjaro o Rybelsus pueden causar pérdida de visión repentina

La Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) informa del riesgo de que los pacientes tratados con semaglutida sufran una neuropatía óptica isquémica anterior no arterítica (NOIANA), una infrecuente reacción adversa que puede causar una brusca pérdida de visión de forma repentina, por lo general en un solo ojo. Leer


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics


ID: 4014223637
Add Watch Country

arrow_drop_down